Thromboangiitis Obliterans: Clinical Trials

3 trials for Thromboangiitis Obliterans, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Thromboangiitis Obliterans: new trials by email Literature Review of Thromboangiitis Obliterans trials Research Report on Thromboangiitis Obliterans

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)
CLBS12, SOC - Critical Limb Ischemia, Buerger Disease
Phase 2CompletedLisata Therapeutics, Inc.332017-11-012024-10-09
A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
Allogeneic Mesenchymal Stem Cells - Critical Limb Ischemia, Buerger's Disease
Phase 2CompletedStempeutics Research Pvt Ltd902012-01-012016-09-13
Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia
Endothelial progenitor cells intramuscular implant - Critical Limb Ischemia
Phase 1 / Phase 2CompletedFondazione IRCCS Policlinico San Matteo di Pavia82009-01-012012-06-14

Narrower conditions

Chronic Limb-Threatening Ischemia (3)

Broader conditions

Arterial Occlusive Diseases (3)  ·  Arteriosclerosis (3)  ·  Atherosclerosis (3)  ·  Cardiovascular Diseases (3)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Ischemia (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Peripheral Arterial Disease (3)  ·  Peripheral Vascular Diseases (3)  ·  Vascular Diseases (3)  ·  Vasculitis (3)

Interventions

Cell- and Tissue-Based Therapy (1)  ·  Standard of Care (1)  ·  betibeglogene autotemcel (1)

Sponsors

Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Lisata Therapeutics, Inc. (1)  ·  Stempeutics Research Pvt Ltd (1)

Countries

India (1)  ·  Italy (1)  ·  Japan (1)

Top investigators

Attilio Odero, Professor (1)  ·  Dr Alfred Augustine (1)  ·  Dr Anirban Chatterjee (1)  ·  Dr Anita Dhar (1)  ·  Dr Murali Krishna (1)  ·  Dr Radhakrishnan R (1)  ·  Dr Rajiv Parakh (1)  ·  Dr Rajkumar M (1)  ·  Dr Sanjay Desai (1)  ·  Dr Santanu Dutta (1)  ·  Dr Vidyasagaran T (1)  ·  Kristen K Buck, MD (1)

Results publications

PMID 26526721